OC
APLT

Oppenheimer & Co’s Applied Therapeutics APLT Stock Holding History

Oppenheimer & Co’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-73,783
Closed -$2.41M – 1259
2020
Q1 		$2.41M Sell
73,783
-20,000
-21% -$809K 0.07% 299
2019
Q4 		$2.56M Buy
+93,783
New +$1.61M 0.06% 347

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Oppenheimer & Co's APLT Position: Q2 2020 in Review

Oppenheimer & Co sold out of Applied Therapeutics (APLT) in Q2 2020, closing a stake of 73,783 shares — an estimated $2.41M sold.

Oppenheimer & Co first reported a position in APLT in Q4 2019 and held it in 2 quarters. The position peaked at $2.56M in Q4 2019. 73 funds tracked by Wall St. Rank hold APLT as of Q2 2020.

  • Oppenheimer & Co reported no remaining Applied Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 73,783 Applied Therapeutics shares in Q2 2020, an estimated $2.41M.
  • Oppenheimer & Co first reported a position in Applied Therapeutics in Q4 2019 and held it in 2 quarters.
  • Oppenheimer & Co's Applied Therapeutics position peaked at $2.56M in Q4 2019.
  • 73 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2020.

Based on Oppenheimer & Co's 13F filing for Q2 2020, filed 11 Aug 2020.